Naoki Tode

459 total citations
15 papers, 220 citations indexed

About

Naoki Tode is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Genetics. According to data from OpenAlex, Naoki Tode has authored 15 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Naoki Tode's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Naoki Tode is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Naoki Tode collaborates with scholars based in Japan. Naoki Tode's co-authors include Masakazu Ichinose, Toshiaki Kikuchi, Shinya Ohkouchi, Masahiko Kanehira, Toshihiro Nukiwa, Masahito Ebina, Hájíme Kurosawa, Yoshinori Okada, Takaaki Akaike and Makoto Kobayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Naoki Tode

14 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Tode Japan 9 90 61 49 42 40 15 220
Ambreen Shaikh India 8 39 0.4× 50 0.8× 171 3.5× 21 0.5× 22 0.6× 14 314
Koichiro Saisho Japan 9 56 0.6× 25 0.4× 34 0.7× 32 0.8× 25 0.6× 17 268
Shaoqing Wu China 10 34 0.4× 45 0.7× 85 1.7× 21 0.5× 17 0.4× 30 255
Paul Oei New Zealand 11 44 0.5× 32 0.5× 73 1.5× 18 0.4× 22 0.6× 19 256
Toshikazu Akioka Japan 9 31 0.3× 47 0.8× 35 0.7× 31 0.7× 13 0.3× 34 264
Satsuki Takahashi Japan 9 98 1.1× 10 0.2× 125 2.6× 47 1.1× 37 0.9× 31 328
Luis Fernández-Pereira Spain 9 30 0.3× 24 0.4× 49 1.0× 34 0.8× 32 0.8× 28 313
Ellie Karampini Netherlands 9 31 0.3× 31 0.5× 71 1.4× 16 0.4× 40 1.0× 12 306
Halldora K. Thorarinsdottir United States 7 30 0.3× 77 1.3× 67 1.4× 41 1.0× 9 0.2× 7 192
Khaldoun Ghazal France 7 41 0.5× 16 0.3× 42 0.9× 23 0.5× 23 0.6× 11 249

Countries citing papers authored by Naoki Tode

Since Specialization
Citations

This map shows the geographic impact of Naoki Tode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Tode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Tode more than expected).

Fields of papers citing papers by Naoki Tode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Tode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Tode. The network helps show where Naoki Tode may publish in the future.

Co-authorship network of co-authors of Naoki Tode

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Tode. A scholar is included among the top collaborators of Naoki Tode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Tode. Naoki Tode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tode, Naoki, Yuri Yamamoto, Shunichi Takeda, et al.. (2024). Hermansky-Pudlak Syndrome with an Improvement in the Respiratory Symptoms after the Administration of Pirfenidone. Internal Medicine. 63(24). 3353–3358. 1 indexed citations
2.
Numakura, Tadahisa, Koji Murakami, Tsutomu Tamada, et al.. (2022). A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review. Internal Medicine. 61(20). 3101–3106. 15 indexed citations
3.
Yamaya, Mutsuo, Shinsuke Nakayama, Naoki Tode, et al.. (2020). Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Yamaya, Mutsuo, Naoki Tode, Aya Yamada, et al.. (2020). <p>Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study</p>. International Journal of COPD. Volume 15. 857–868. 20 indexed citations
5.
Makiguchi, Tomonori, Akira Koarai, Chihiro Inoue, et al.. (2020). A case of localized tracheobronchial relapsing polychondritis with positive matrilin-1 staining. BMC Rheumatology. 4(1). 1–1.
6.
Ohkouchi, Shinya, Naoki Tode, Makoto Kobayashi, et al.. (2018). Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis. ERJ Open Research. 4(1). 71–2017. 3 indexed citations
7.
Tode, Naoki, Toshiaki Kikuchi, Tomohiro Sakakibara, et al.. (2017). Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor‐mutant lung cancer. Cancer Science. 108(6). 1263–1270. 10 indexed citations
8.
Kikuchi, Toshiaki, Naoki Tode, Mitsuhiro Yamada, et al.. (2016). OX 40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia. EMBO Molecular Medicine. 8(4). 422–436. 7 indexed citations
9.
Okada, Shinji, et al.. (2016). Improving Physical Activity Ensures the Long-Term Survival of Pneumonia Patients in a Super-Aged Society: A Retrospective Study in an Acute-Care Hospital in Japan. The Tohoku Journal of Experimental Medicine. 238(3). 237–245. 9 indexed citations
10.
Kikuchi, Toshiaki, Naoki Tode, Hozumi Motohashi, et al.. (2015). Syndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation. Molecular Therapy. 24(1). 41–52. 9 indexed citations
11.
Ono, Manabu, Shinya Ohkouchi, Masahiko Kanehira, et al.. (2014). Mesenchymal Stem Cells Correct Inappropriate Epithelial–mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1. Molecular Therapy. 23(3). 549–560. 93 indexed citations
12.
Kanehira, Masahiko, Toshiaki Kikuchi, Naoki Tode, et al.. (2014). Human Marrow Stromal Cells Downsize the Stem Cell Fraction of Lung Cancers by Fibroblast Growth Factor 10. Molecular and Cellular Biology. 34(15). 2848–2856. 8 indexed citations
13.
Kikuchi, Toshiaki, Yoshihiro Kobashi, Naoki Tode, et al.. (2013). Mycobacterium avium genotype is associated with the therapeutic response to lung infection. Clinical Microbiology and Infection. 20(3). 256–262. 10 indexed citations
14.
Kanehira, Masahiko, Toshiaki Kikuchi, Shinya Ohkouchi, et al.. (2012). Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells. PLoS ONE. 7(2). e32185–e32185. 20 indexed citations
15.
Kikuchi, Toshiaki, Tomohiro Sakakibara, K Gomi, et al.. (2011). Mycobacterial hypersensitivity pneumonitis requires TLR9–MyD88 in lung CD11b+ CD11c+ cells. European Respiratory Journal. 38(3). 688–701. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026